Insulet CEO on earnings, GLP-1 and election impact
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Closing Bell: Overtime Jim Hollingshead, Insulet CEO, joins ‘Closing Bell: Overtime’ to discuss the Insulet earnings, Apple blood sugar testing app and more. 03:20 37 minutes ago Source link